Amylyx Pharmaceuticals, Inc. (AMLX)
27.79
-0.29
(-1.03%)
USD |
NASDAQ |
Oct 02, 16:00
27.80
+0.01
(+0.04%)
After-Hours: 20:00
Amylyx Pharmaceuticals Market Cap : 3.095B for Oct. 2, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 02, 2026 | 3.095B |
| October 01, 2026 | 3.127B |
| September 30, 2026 | 3.241B |
| September 29, 2026 | 3.261B |
| September 28, 2026 | 3.324B |
| September 25, 2026 | 3.284B |
| September 24, 2026 | 3.357B |
| September 23, 2026 | 3.408B |
| September 22, 2026 | 3.675B |
| September 21, 2026 | 3.607B |
| September 18, 2026 | 3.609B |
| September 17, 2026 | 3.780B |
| September 16, 2026 | 3.634B |
| September 15, 2026 | 3.692B |
| September 14, 2026 | 3.746B |
| September 11, 2026 | 3.521B |
| September 10, 2026 | 3.574B |
| September 09, 2026 | 3.608B |
| September 08, 2026 | 3.773B |
| September 04, 2026 | 3.798B |
| September 03, 2026 | 3.782B |
| September 02, 2026 | 3.841B |
| September 01, 2026 | 3.765B |
| August 31, 2026 | 3.759B |
| August 28, 2026 | 3.869B |
| Date | Value |
|---|---|
| August 27, 2026 | 4.141B |
| August 26, 2026 | 4.130B |
| August 25, 2026 | 4.172B |
| August 24, 2026 | 4.249B |
| August 21, 2026 | 4.305B |
| August 20, 2026 | 4.417B |
| August 19, 2026 | 4.299B |
| August 18, 2026 | 3.910B |
| August 17, 2026 | 2.387B |
| August 14, 2026 | 2.409B |
| August 13, 2026 | 2.504B |
| August 12, 2026 | 2.600B |
| August 11, 2026 | 2.632B |
| August 10, 2026 | 2.525B |
| August 07, 2026 | 2.541B |
| August 06, 2026 | 2.694B |
| August 05, 2026 | 2.433B |
| August 04, 2026 | 2.436B |
| August 03, 2026 | 2.239B |
| July 31, 2026 | 2.255B |
| July 30, 2026 | 2.304B |
| July 29, 2026 | 2.191B |
| July 28, 2026 | 2.171B |
| July 27, 2026 | 2.164B |
| July 24, 2026 | 2.044B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Pfizer Inc. | 158.43B |
| Eli Lilly & Co. | 1.076T |
| Merck & Co., Inc. | 356.23B |
| EyePoint, Inc. | 276.19M |
| Bristol Myers Squibb Co. | 124.93B |
Market Cap Related Metrics
| Price to Book Value | 12.94 |
| Price | 27.79 |
| Earnings Yield | -5.16% |